Navigation Links
Treatment-resistant hypertension requires proper diagnosis

High blood pressurealso known as hypertensionis widespread, but treatment often fails. One in five people with hypertension does not respond to therapy. This is frequently due to inadequate diagnosis, as Franz Weber and Manfred Anlauf point out in the current issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2014; 111: 42531).

If a patient's blood pressure is not controlled by treatment, this can be due to a number of reasons. Often it is the medication the patient is on. Some patients may be taking other medicines in addition to their antihypertensive therapy which increase blood pressure as a side effect. In these cases, the treatment of the high blood pressure appears to be ineffective, but all that would be needed is some adjustment to the medication regimen. Then there is diet. Licorice, for example, does increase blood pressure; so eating too much of it may reduce the effect of the antihypertensive therapy. Likewise, salt-sensitive patients may increase their blood pressure by eating salt; thus they have to keep this in mind when seasoning their dishes.

Besides drugs and food, certain symptoms may interfere with antihypertensive therapy. Once the underlying condition has been successfully treated, blood pressure control does often improve. An example for this is the sleep apnea syndrome: Apart from sleep problems and fatigue, it makes high blood pressure worse. Here, most patients find their blood pressure improved with targeted treatment of the apnea and quite often the antihypertensive medication can be reduced.

Thus rigorous diagnostic evaluation is key to a successful treatment of hypertension. In their current study the authors expect that with this approach almost half of the cases classified as treatment-resistant hypertension could be treated.


Contact: Dr. Franz Weber
Deutsches Aerzteblatt International

Page: 1

Related medicine news :

1. A new route for tackling treatment-resistant prostate cancer
2. Some patients with treatment-resistant colorectal cancers may have a new option
3. Reprogrammed treatment-resistant lymphomas respond to cancer drugs
4. Potential new drug for some patients with treatment-resistant lung cancer
5. Cleveland Clinic receives grant to study role of DNA damage in treatment-resistant prostate cancer
6. Experimental drug shows promise for treatment-resistant leukemias
7. PSMA-based imaging traces even treatment-resistant prostate cancer
8. Researchers uncover new insights into developing rapid-acting antidepressant for treatment-resistant depression
9. URMC clinical trial tests new regimen for hypertension
10. Pittsburgh Cardiologist Named Physician of the Year by Pulmonary Hypertension Association
11. UGA study shows why hypertension increases damage to eyes of diabetic patients
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: